Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Oct 6, 2017
Finance

Coasting on catalysts

Investors are watching CAR T, ASH, ophthalmology and Orphan therapies in 4Q17
BioCentury | Aug 15, 2016
Clinical News

Voretigene neparvovec: Additional Phase III data

BioCentury | Oct 19, 2015
Clinical News

AAV2-hRPE65v2: Additional Phase III data

BioCentury | Oct 12, 2015
Clinical News

AAV2-hRPE65v2: Phase III data

BioCentury | Jul 13, 2015
Finance

Big news

Biotech names and milestones investors like heading into 2H15
Items per page:
1 - 10 of 27